203 related articles for article (PubMed ID: 19023136)
1. New technologies for delineating and characterizing the lipid exome: prospects for understanding familial combined hyperlipidemia.
Horswell SD; Ringham HE; Shoulders CC
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S370-5. PubMed ID: 19023136
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
[TBL] [Abstract][Full Text] [Related]
3. Novel genes for familial combined hyperlipidemia.
Aouizerat BE; Allayee H; Bodnar J; Krass KL; Peltonen L; de Bruin TW; Rotter JI; Lusis AJ
Curr Opin Lipidol; 1999 Apr; 10(2):113-22. PubMed ID: 10327279
[TBL] [Abstract][Full Text] [Related]
4. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
5. [Familial combined hyperlipidemia].
de Bruin TW; Dallinga-Thie GM; Erkelens DW
Ned Tijdschr Geneeskd; 1996 Oct; 140(43):2118-21. PubMed ID: 8965962
[No Abstract] [Full Text] [Related]
6. [Lipid metabolism disorders--diagnosis and therapy in general practice. 8: Mixed hyperlipoproteinemias].
Richter WO
Fortschr Med; 1996 Jul; 114(18-19):248-50. PubMed ID: 8766794
[No Abstract] [Full Text] [Related]
7. [Fifty years studying hiperlipidemias: the case of familial combined hyperlipidemia].
Aguilar-Salinas C; Gómez-Díaz R; Tusié-Luna MT
Invest Clin; 2010 Jun; 51(2):145-58. PubMed ID: 20928976
[TBL] [Abstract][Full Text] [Related]
8. Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies.
Taghizadeh E; Esfehani RJ; Sahebkar A; Parizadeh SM; Rostami D; Mirinezhad M; Poursheikhani A; Mobarhan MG; Pasdar A
IUBMB Life; 2019 Sep; 71(9):1221-1229. PubMed ID: 31271707
[TBL] [Abstract][Full Text] [Related]
9. Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.
Gaddi A; Cicero AF; Odoo FO; Poli AA; Paoletti R;
Vasc Health Risk Manag; 2007; 3(6):877-86. PubMed ID: 18200807
[TBL] [Abstract][Full Text] [Related]
10. Phenotype expression in familial combined hyperlipidemia.
Porkka KV; Nuotio I; Pajukanta P; Ehnholm C; Suurinkeroinen L; Syvänne M; Lehtimäki T; Lahdenkari AT; Lahdenperä S; Ylitalo K; Antikainen M; Perola M; Raitakari OT; Kovanen P; Viikari JS; Peltonen L; Taskinen MR
Atherosclerosis; 1997 Sep; 133(2):245-53. PubMed ID: 9298685
[TBL] [Abstract][Full Text] [Related]
11. Frequent detection of familial hypercholesterolemia mutations in familial combined hyperlipidemia.
Jarvik GP; Brunzell JD; Motulsky AG
J Am Coll Cardiol; 2008 Nov; 52(19):1554-6. PubMed ID: 19007591
[No Abstract] [Full Text] [Related]
12. [Familial combined hyperlipidemia].
Mabuchi H; Nohara A; Nozue T; Koizumi J; Uno Y
Nihon Naika Gakkai Zasshi; 2001 Aug; 90(8):1538-43. PubMed ID: 11573278
[No Abstract] [Full Text] [Related]
13. Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group.
Gaddi A; Galetti C; Pauciullo P; Arca M
Nutr Metab Cardiovasc Dis; 1999 Dec; 9(6):304-11. PubMed ID: 10765523
[TBL] [Abstract][Full Text] [Related]
14. [Congenital defects of post-heparin lipoprotein lipase. Diagnosis of familial combined lipoproteinemia].
Titov VN
Klin Lab Diagn; 2003 Jun; (6):10-7. PubMed ID: 12910637
[No Abstract] [Full Text] [Related]
15. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia.
Solanas-Barca M; de Castro-Orós I; Mateo-Gallego R; Cofán M; Plana N; Puzo J; Burillo E; Martín-Fuentes P; Ros E; Masana L; Pocoví M; Civeira F; Cenarro A
Atherosclerosis; 2012 Jun; 222(2):449-55. PubMed ID: 22481068
[TBL] [Abstract][Full Text] [Related]
16. [Familial combined hyperlipidemia].
Sasaki J
Nihon Rinsho; 1999 Dec; 57(12):2776-81. PubMed ID: 10638212
[TBL] [Abstract][Full Text] [Related]
17. Is familial combined hyperlipidaemia a genetic disorder of adipose tissue?
Arner P
Curr Opin Lipidol; 1997 Apr; 8(2):89-94. PubMed ID: 9183546
[TBL] [Abstract][Full Text] [Related]
18. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
[TBL] [Abstract][Full Text] [Related]
19. A proposal to redefine familial combined hyperlipidaemia -- third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation.
Sniderman AD; Castro Cabezas M; Ribalta J; Carmena R; de Bruin TW; de Graaf J; Erkelens DW; Humphries SE; Masana L; Real JT; Talmud PJ; Taskinen MR
Eur J Clin Invest; 2002 Feb; 32(2):71-3. PubMed ID: 11895451
[No Abstract] [Full Text] [Related]
20. Pathway analysis detect potential mechanism for familial combined hyperlipidemia.
Wang YL; Xue F; Liu LZ; He ZH
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1909-15. PubMed ID: 23877856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
